menu
    • menu

    Company profile for Inventia Healthcare Limited

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Inventia, is a pharmaceutical development and manufacturing company based in Mumbai, India with over 30 years of operations. Our focus is on development of value added oral solid dosage formulations (“OSDF”). We develop and manufacture our products in-house. Once developed, we partner with clients across the globe. Inventia’s presence has progressively increased to 28 countries globally. By working closely with our clie...
    Inventia, is a pharmaceutical development and manufacturing company based in Mumbai, India with over 30 years of operations. Our focus is on development of value added oral solid dosage formulations (“OSDF”). We develop and manufacture our products in-house. Once developed, we partner with clients across the globe. Inventia’s presence has progressively increased to 28 countries globally. By working closely with our clients, we believe in building and nurturing a long-term trusted relationship - with an aim to be their preferred development and manufacturing partner for any market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Inventia Healthcare Limitedindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Unit 703 and 704, 7th Floor, Hubtown Solaris, N S Phadke Marg, Andheri (East),...
    Telephone
    Telephone
    +91 22 67163000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.inventiahealthcare.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/inventia-healthcare
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Inventia’s Generics Dapagliflozin Receives Tentative Nod in US
    Inventia’s Generics Dapagliflozin Receives Tentative Nod in US

    09 Apr 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219755

    FDA
    09 Apr 2026
    Share Share
    Inventia Launches FDA-Approved Dapagliflozin in the U.S.
    Inventia Launches FDA-Approved Dapagliflozin in the U.S.

    08 Apr 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/inventia-enters-the-u-s-market-with-fda-approved-dapagliflozin-tablets/

    EXPRESSPHARMA
    08 Apr 2026
    Share Share
    Inventia’s Generics Sitagliptin Receives Tentative Approval in US
    Inventia’s Generics Sitagliptin Receives Tentative Approval in US

    25 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217829

    FDA
    25 Mar 2026
    Share Share
    Inventia Hlthcare Generics Dapagliflozin Receives Approval in US
    Inventia Hlthcare Generics Dapagliflozin Receives Approval in US

    21 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211156

    FDA
    21 Nov 2025
    Share Share
    Statement of total voting rights and shares forming the company's share capital
    Statement of total voting rights and shares forming the company's share capital

    28 Apr 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/04/28/2431650/0/en/Statement-of-total-voting-rights-and-shares-forming-the-company-s-share-capital-as-of-April-11-2022.html

    GLOBENEWSWIRE
    28 Apr 2022
    Share Share
    Inventia's Generic Chlorthalidone Receives Approval in the U.S.
    Inventia's Generic Chlorthalidone Receives Approval in the U.S.

    09 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211320

    FDA
    09 Feb 2022
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Inventia Healthcare Limited and get a quotation

    Inventia Healthcare Limited is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find Lansoprazole bulk offered by Inventia Healthcare Limited

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search